Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,679.29
1,198.17
1,017.90
1,020.80
995.09
775.88
427.22
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,679.29
1,198.17
1,017.90
1,020.80
995.09
775.88
427.22
Raw Material Cost
1,195.09
1,039.17
853.79
824.65
741.81
497.73
269.86
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14.12
43.02
28.61
18.82
3.27
2.62
2.19
Selling and Distribution Expenses
130.41
91.82
117.03
92.71
74.67
85.94
60.10
Other Expenses
5.76
0.41
0.81
1.49
3.40
2.39
1.73
Total Expenditure (Excl Depreciation)
1,397.19
1,178.12
1,007.53
951.11
853.76
610.14
349.45
Operating Profit (PBDIT) excl Other Income
282.1
20.099999999999998
10.4
69.7
141.3
165.7
77.8
Other Income
22.91
20.80
22.69
13.25
16.66
16.49
7.94
Operating Profit (PBDIT)
420.91
151.31
149.37
136.77
181.10
197.51
93.44
Interest
14.12
43.02
28.61
18.82
3.27
2.62
2.19
Exceptional Items
2.24
-23.99
12.01
1.46
1.55
0.23
0.00
Gross Profit (PBDT)
484.21
159.00
164.11
196.15
253.28
278.16
157.36
Depreciation
120.38
113.27
120.32
62.69
28.54
19.08
12.65
Profit Before Tax
288.65
-28.97
12.44
56.71
150.83
176.03
78.60
Tax
35.17
-9.20
-4.34
4.00
17.97
25.88
9.84
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
253.16
-20.16
16.78
52.71
132.87
150.16
68.77
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
253.16
-20.16
16.78
52.71
132.87
150.16
68.77
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.33
0.38
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
253.49
-19.77
16.78
52.71
132.87
150.16
68.77
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,173.65
1,457.58
1,509.28
1,541.43
1,618.85
1,379.15
378.28
Earnings per share (EPS)
1.29
-0.12
0.1
0.32
0.8
0.91
0.41
Diluted Earnings per share
1.29
-0.12
0.1
0.32
0.8
0.91
0.41
Operating Profit Margin (Excl OI)
16.53%
1.44%
0.62%
5.96%
13.66%
20.87%
17.05%
Gross Profit Margin
24.36%
7.04%
13.04%
11.7%
18.03%
25.15%
21.36%
PAT Margin
15.08%
-1.68%
1.65%
5.16%
13.35%
19.35%
16.1%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 40.15% vs 17.71% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 1,380.30% vs -217.86% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 204.98% vs 3.00% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -67.21% vs 50.35% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of HVSEN Biotechnology Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,679.29
0
1,679.29
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,679.29
0
1,679.29
Raw Material Cost
1,195.09
0
1,195.09
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
14.12
0
14.12
Selling and Distribution Expenses
130.41
0
130.41
Other Expenses
5.76
0.00
5.76
Total Expenditure (Excl Depreciation)
1,397.19
0
1,397.19
Operating Profit (PBDIT) excl Other Income
282.10
0.00
282.10
Other Income
22.91
0
22.91
Operating Profit (PBDIT)
420.91
0
420.91
Interest
14.12
0
14.12
Exceptional Items
2.24
0
2.24
Gross Profit (PBDT)
484.21
0
484.21
Depreciation
120.38
0
120.38
Profit Before Tax
288.65
0
288.65
Tax
35.17
0
35.17
Provisions and contingencies
0
0
0.00
Profit After Tax
253.16
0
253.16
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
253.16
0
253.16
Share in Profit of Associates
0
0
0.00
Minority Interest
0.33
0
0.33
Other related items
0.00
0.00
0.00
Consolidated Net Profit
253.49
0
253.49
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,173.65
0
2,173.65
Earnings per share (EPS)
1.29
0
1.29
Diluted Earnings per share
1.29
0
1.29
Operating Profit Margin (Excl OI)
16.53%
0%
0.00
16.53%
Gross Profit Margin
24.36%
0%
0.00
24.36%
PAT Margin
15.08%
0%
0.00
15.08%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 167.93 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 40.15% vs 17.71% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 25.35 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 1,380.30% vs -217.86% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 39.80 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 204.98% vs 3.00% in Dec 2024
Annual - Interest
Interest 1.41 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -67.21% vs 50.35% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.53%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






